Acadia Healthcare Company, Inc.

ACHC · Nasdaq · ·

Karşılaştır

$37,79-%2,612 Kas kapanış

30 Eylül 2026 tarihine kadarki rakamlar, 4 Kasım 2026 tarihinde sunulan 10-Q raporundan

1W: +%2,1
1M: +%19,3

Just reported

Q3 2026 results

From Acadia Healthcare's results release of 4 Kasım 2026; its quarterly report has since been filed.

Revenue
Actual
$895,3M
+%5,1 y/y
+%3,4 q/q
Guided
—
No guide given
EPS, GAAP
Actual
$0,38
-%5,0 y/y
+%217 q/q
Guided
—
No guide given

Company outlook

Full year 2026

Revenue$3,44B – $3,46B+%4,1 y/y Raised +%0,7
EPS, adjusted$1,70 – $1,80Raised +%15

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Acadia Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Seçki
Health insurers & hospitals
InspectStocks tarafından · 17 companies
Health insurers, pharmacy benefit managers and hospital and clinic operators.
Fiyat, 1 yıl
+%25,1
Gelir, 1 yıl
+%7,0
+11
A 6B 3C 6D 2

Highest-graded in Medical Care Facilities

Graded A or B and worth $2B or more: A first, then the largest.

All 44 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Tüm finansal tablolar →

Acadia Healthcare Company, Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.

Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.

Q3 2026 results

Revenue